Theratechnologies (TH) Hits New 52-Week Low at $5.90

Shares of Theratechnologies Inc (TSE:TH) reached a new 52-week low on Tuesday . The company traded as low as C$5.90 and last traded at C$5.97, with a volume of 91203 shares traded. The stock had previously closed at C$6.05.

A number of analysts recently weighed in on the stock. Stifel Nicolaus assumed coverage on shares of Theratechnologies in a research note on Tuesday, May 14th. They set a “buy” rating and a C$15.00 target price on the stock. Echelon Wealth Partners restated a “buy” rating on shares of Theratechnologies in a research note on Friday, February 22nd. Royal Bank of Canada cut their target price on shares of Theratechnologies from C$12.00 to C$10.00 and set a “sector perform” rating on the stock in a research note on Friday, February 22nd. Finally, National Bank Financial cut their target price on shares of Theratechnologies from C$14.25 to C$12.75 and set an “outperform” rating on the stock in a research note on Thursday, February 21st.

The company has a current ratio of 2.46, a quick ratio of 1.97 and a debt-to-equity ratio of 145.32. The company has a market capitalization of $440.72 million and a price-to-earnings ratio of -122.65.

In related news, Senior Officer Marie-Noël Colussi sold 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 26th. The stock was sold at an average price of C$9.17, for a total value of C$27,510.00. Following the completion of the transaction, the insider now directly owns 23,075 shares of the company’s stock, valued at C$211,597.75.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Virtu Financial LLC acquired a new stake in shares of Theratechnologies in the first quarter valued at approximately $96,000. Mesirow Financial Investment Management Inc. acquired a new stake in shares of Theratechnologies in the first quarter valued at approximately $328,000. BlackRock Inc. acquired a new stake in shares of Theratechnologies in the first quarter valued at approximately $1,140,000. LLBH Private Wealth Management LLC acquired a new stake in shares of Theratechnologies in the first quarter valued at approximately $1,735,000. Finally, Monarch Partners Asset Management LLC acquired a new stake in shares of Theratechnologies in the first quarter valued at approximately $4,256,000.

TRADEMARK VIOLATION WARNING: “Theratechnologies (TH) Hits New 52-Week Low at $5.90” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.dispatchtribunal.com/2019/05/21/theratechnologies-th-hits-new-52-week-low-at-5-90.html.

About Theratechnologies (TSE:TH)

Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States.

Featured Story: Leveraged Buyout (LBO)

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.